Psychedelic microdosing benefits and challenges: an empirical codebook
Thomas Anderson, Rotem Petranker, Adam Christopher, Daniel Rosenbaum, Cory R. Weissman, Lê-Anh Dinh-Williams, Katrina Hui, Emma Hapke
Harm Reduction Journal July 9, 2019 DOI: 10.1186/s12954-019-0308-4 via OpenAlex
Summary
AI-generated from the abstractA mixed-methods study of an active microdosing community categorizes the experiences participants report, identifying high-potential avenues for future scientific research. The resulting taxonomy distills intervention targets from participant reports to help allocate research funding efficiently. Microdosing research complements full-dose psychedelic studies as clinical treatments and neuropharmacological mechanisms are developed. The framework aims to guide researchers and clinicians as experimental microdosing research begins in earnest.
Study at a glance
| Characteristics | Mixed-methods study Peer reviewed |
|---|---|
| Population | Active microdosing community |
| Intervention | Microdosing |
| Topics | LSD Psilocybin |
| Keywords | Hallucinogen Popularity Psychology |
| Citations | 130 |
| Key finding | The MDBC taxonomy distills high-potential intervention targets from participant reports to inform efficient allocation of research funding. |
Abstract
These mixed-methods results help summarize and frame the experiences reported by an active microdosing community as high-potential avenues for future scientific research. The MDBC taxonomy reported here informs future research, leveraging participant reports to distil the highest-potential intervention targets so research funding can be efficiently allocated. Microdosing research complements the full-dose literature as clinical treatments are developed and neuropharmacological mechanisms are sought. This framework aims to inform researchers and clinicians as experimental microdosing research begins in earnest in the years to come.